Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications in Hematology
Ethical and Legal Considerations Regarding the Ownership and Commercial Use of Human Biological Materials and Their Derivatives [Corrigendum]
Journal of Blood Medicine
Hematology
Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Autologous Transplant: Full Results After Extended Follow-Up of the Phase 2 Checkmate 205 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Efficacy of Ibrutinib in Patients With Relapsed Mantle Cell Lymphoma After First Line Intensive Chemo-Immunotherapy and Asct - A Retrospective Study From the LWP-Ebmt
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The 5-Year Follow-Up Results of the C5r Protocol With Rituximab and Intrathecal Liposomal Cytarabine for Primary CNS Lymphoma: A Prospective Phase 2 Study of the Lysa
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Impact of Pet Imaging and Histologic Transformation on the Prognosis of Early Disease Progression in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
CeVi: A UNIQUE CRYOPRESERVED HUMAN VIABLE CELL COLLECTION FROM LYMPHOMA PATIENTS, a CALYM INITIATIVE TO ACCELERATE INNOVATION AND ITS TRANSFER TO LYMPHOMA FIELD
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Multi-Center Phase Ii Study of Oral Azacitidine (Cc-486) Plus Chop as Initial Treatment for Peripheral T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combination of TGR-1202, Ublituximab, and Bendamustine Is Safe and Highly Active in Patients With Advanced DLBCL and Follicular Lymphoma.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Cross-Sectional Study Examining How Knowledge of Lymphoma Subtype Affects the Patient Experience
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Effect of Dose Modifications on Response to Duvelisib in Patients With Relapsed/Refractory CLL/SLL in the Duo Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
‹
672
673
674
675
676
677
678
›